Harpoon Therapeutics Competitors and Similar CompaniesClear all
Harpoon Therapeutics's competitors and similar companies include Olema Oncology and ImmunoGen.
 Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | ||
Founding Date | Founding Date 2015 | Founding Date 2007 | Founding Date 1981 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ Louisville, US South San Francisco, US | Locations San Francisco, US HQ San Francisco, US | Locations Waltham, US HQ |
Employees | Employees 45 | Employees 9630% increase | Employees 277161% increase |
Valuation ($) | Valuation ($) 492.3 m | Valuation ($) 679.2 m | Valuation ($) 8.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) $31.9m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $108.8m (FY, 2022) |
Net income | Net income ($67.7m) (FY, 2022) | Net income ($162.5m) (FY, 2025) | Net income ($222.9m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 130m | Total funding raised $ 145.1m | Total funding raised $ 56m |
For sources of this data, please see the company profile
View Company Profiles
Olema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View companyImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company